Featured Research

from universities, journals, and other organizations

What Makes Clostridium Difficile Superbug Deadly?

Date:
March 1, 2009
Source:
Loyola University Health System
Summary:
Researchers have identified what Clostridium difficile toxin causes disease in humans. The study reveals that for decades researchers have been focusing on the wrong toxin that is released by the bacteria in the colon.

Joan Corboy of Wilmette, Ill., thanks Dr. Stuart Johnson, left, and Dr. Dale Gerding for providing the medical care to overcome a Clostridium difficile (C-diff) infection that caused her to lose 55 pounds in less than six months. Gerding and Johnson co-authored a study that answers how C-diff causes disease in humans.
Credit: Photo by Al Hayashi/Loyola University Health System

A major breakthrough about the potentially deadly superbug Clostridium difficile (C-diff) could lead to new ways to combat the bacterium, according to a study to be published in the journal Nature.

The study reveals that for decades researchers have been focusing on the wrong toxin that is released by the bacteria in the colon. The toxin can cause severe diarrhea and life-threatening colitis that could lead to the surgical removal of the colon.

"For 20 years, we have been focusing on Toxin A. But it turns out the real culprit is Toxin B," said study co-author Dr. Dale Gerding. "This is a major finding in how C-diff causes disease in humans. It completely flips our whole concept of what the important toxin is with this disease."

Gerding is a professor of medicine, division of infectious diseases, Loyola University Chicago Stritch School of Medicine, Maywood, Ill., and associate chief of staff for Research, Hines VA Hospital.

C-diff is a spore-forming bacterium that was discovered in 1978 to be the cause of antibiotic-associated diarrhea and colitis. It is rapidly spreading through health-care facilities around the globe. When the normal bacteria that live in the colon are disturbed, usually as a result of antibiotic treatment, and a patient ingests C-diff spores, the bacteria can multiply and release the two toxins.

C-diff sickens about 500,000 Americans a year, contributing to 15,000 to 20,000 deaths, The epidemic strain has been found in 38 states, including Illinois. It now rivals the superbug known as MRSA as one of the top emerging disease threats to humans. Since its discovery, C-diff has grown increasingly resistant to antibiotics. Though it is appearing more often in younger people, those 65 years and older face a greater risk of developing infection from C-diff and have more severe outcomes and higher death rates.

Symptoms of C-diff include profuse diarrhea and abdominal pain and distention of the abdomen. An infection is also frequently accompanied by fever, nausea and dehydration. In some rare cases blood may be present in the stool. The infection is spread by spores that contaminate the hospital environment and hands of healthcare workers who can transmit the spores to patients. The resistance of the spores to hospital cleaning agents and to alcohol hand disinfectants makes it extremely difficult to eradicate.

Gerding noted that a human clinical trial using a drug that bound Toxin A more than it bound Toxin B failed to treat C-diff effectively.

"There's probably a good reason why the trial failed," Gerding said. "We now know that Toxin B should have been the primary target." –

The study has major implications for the future development of treatments and preventative measures for C-diff, said Gerding and co-author Dr. Stuart Johnson, associate professor of medicine, division of infectious diseases, Loyola University Chicago Stritch School of Medicine.

"The more you understand the way an organism causes disease, the better you can target treatment or preventative measures," said Johnson, who has treated dozens of C-diff patients.

The breakthrough in the study came after co-authors in Australia engineered mutant strains of the bacteria that were tested by Gerding and other Loyola researchers.

"It turns out that in the strain in which Toxin A was knocked out, the organism was fully virulent. It caused disease," Johnson said. "When they knocked the Toxin B out in another set of experiments, the organism didn't cause disease. This is probably the best evidence to date about the relative importance of these two toxins."


Story Source:

The above story is based on materials provided by Loyola University Health System. Note: Materials may be edited for content and length.


Journal Reference:

  1. Lyras et al. Toxin B is essential for virulence of Clostridium difficile. Nature, 2009; DOI: 10.1038/nature07822

Cite This Page:

Loyola University Health System. "What Makes Clostridium Difficile Superbug Deadly?." ScienceDaily. ScienceDaily, 1 March 2009. <www.sciencedaily.com/releases/2009/03/090301181417.htm>.
Loyola University Health System. (2009, March 1). What Makes Clostridium Difficile Superbug Deadly?. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2009/03/090301181417.htm
Loyola University Health System. "What Makes Clostridium Difficile Superbug Deadly?." ScienceDaily. www.sciencedaily.com/releases/2009/03/090301181417.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
Can Watching TV Make You Feel Like A Failure?

Can Watching TV Make You Feel Like A Failure?

Newsy (July 24, 2014) A study by German researchers claims watching TV while you're stressed out can make you feel guilty and like a failure. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins